Exhaled NO may predict loss of asthma control: the effect of concomitant allergic rhinitis

It is well documented that the use of medications in asthma and allergic rhinitis is often suboptimal, and consequently, patients remain symptomatic. This study aimed to determine the extent and type of medication-related issues contributing to poor asthma control by profiling medication management in those most at risk—a population with clinically uncontrolled asthma. Participants (n = 363) were recruited from Australian community pharmacies, and a dispensed medication history report for the previous 12 months was collected to examine medication adherence and factors affecting adherence. Information was also collected regarding participant asthma control and asthma/allergic rhinitis (if applicable) management. The participants’ mean asthma control score was 2.49 (± 0.89 SD, IQR = 1.20) (score ≥ 1.5 indicative of poorly controlled asthma), and 72% were either non-adherent or yet to initiate preventer therapy. Almost half had been prescribed high doses of inhaled corticosteroid and 24% reported use of oral corticosteroids. Only 22% of participants with concomitant allergic rhinitis were using first line treatment. A logistic regression model highlighted that participant health care concession status and hospital admissions were associated with better adherence. Suboptimal medication management is evident in this at-risk population.

Download Full-text

Rhinitis, sinusitis and ocular disease – 2098. Exhaled NO may predict development of allergic rhinitis in children with asthma

World Allergy Organization Journal ◽

10.1186/1939-4551-6-s1-p174 ◽

2013 ◽

Vol 6 ◽

pp. P174

Author(s):

Yeong Ho Rha ◽

Han Seok Ko

Keyword(s):

Allergic Rhinitis ◽

Ocular Disease ◽

Exhaled No ◽

Children With Asthma

Download Full-text

Evaluation of Allergic Rhinitis and Asthma Control in a Portuguese Community Pharmacy Setting

Journal of Managed Care Pharmacy ◽

10.18553/jmcp.2014.20.5.513 ◽

2014 ◽

Vol 20 (5) ◽

pp. 513-522 ◽

Cited By ~ 7

Author(s):

Olga Lourenço ◽

Sofia Calado ◽

Ana Sá-Sousa ◽

João Fonseca

Keyword(s):

Allergic Rhinitis ◽

Community Pharmacy ◽

Asthma Control ◽

Pharmacy Setting

Download Full-text

Three-month Effects of Immunotherapy on Clinical Features and Pulmonary Function Tests of Patients with Allergic Rhinitis Concomitant with or without Asthma

Acta Medica ◽

10.32552/2020.actamedica.516 ◽

2020 ◽

Vol 51 (4) ◽

pp. 41-47

Author(s):

Guzin Ozden ◽

Pelin Duru Cetinkaya

Keyword(s):

Allergic Rhinitis ◽

Pulmonary Function ◽

Asthma Control ◽

Pulmonary Function Test ◽

Test Scores ◽

Pulmonary Function Tests ◽

Control Test ◽

Asthma Control Test ◽

Function Test ◽

Pre Treatment

Objective: We aimed to evaluate our patient’s treatment responses to three-month immunotherapy for allergic rhinitis with or without asthma, and to investigate the factors affecting treatment Material and Methods: A total of 53 patients receiving subcutaneous immunotherapy for allergic rhinitis with or without asthma were included in the study. All patients were positive for mite skin prick test. Asthma was present as a concomitant disease in 28(52.8%) patients. Patients with and without asthma were classified in two groups as “Allergic rhinitis + Asthma+” and “Allergic rhinitis+ Asthma-“. The values of pulmonary function tests of all patients, and in rhinitis with asthma patients, the Asthma Control Test scores before and after three months of treatment were recorded. Results: In “Allergic rhinitis + Asthma+” and “Allergic rhinitis + Asthma-“groups, male/female ratio was 7/21 and 10/15, mean age was 33±9 and 32±9 years. No statistically significant differences were present between the pre-treatment and 3-month-treatment values of pulmonary function test. The difference between the pre-treatment and 3-month treatment asthma control test scores was strongly significant. Conclusion: In allergic rhinitis, which is quite commonly associated with asthma, the control of asthma is also provided with the treatment of allergic rhinitis. By using pulmonary function test in allergic rhinitis and asthma control test in asthma, we showed that the effectiveness of allergen specific immunotherapy started in 3 months which was earlier from current literature.

Download Full-text